Frank Hulstaert studied medicine in Ghent (MD, 1985), informatics in Brussels (MSc) and biostatistics at Hasselt University, Belgium. He started a residency in internal medicine but soon turned to industry, where he worked at Applied Artificial Intelligence, IBM, Becton and Dickinson, Sandoz/Novartis and Innogenetics. He was mainly involved in the development of in vitro diagnostics, pharmaceuticals and biopharmaceuticals, as a medical expert and later as medical director. He joined the Belgian Health Care Knowledge Centre (KCE) in 2004. As a senior researcher, he is mainly involved in health technology assessments and since 2016 also in KCE Trials, a program of publicly funded practice-oriented trials. During the Covid pandemic, he coordinated the non-commercial Covid clinical trials in Belgium.
